ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1,650 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 1,650 | -5.7% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 1,750 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 1,750 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 1,750 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 1,750 | +6.1% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 1,650 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 1,650 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2020 | $5,000 | -44.4% | 4,451 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $9,000 | -10.0% | 4,451 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $10,000 | -44.4% | 4,451 | -36.0% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | -5.3% | 6,951 | +26.4% | 0.00% | 0.0% |
| Q1 2019 | $19,000 | +58.3% | 5,500 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $12,000 | +71.4% | 5,500 | +214.3% | 0.00% | -50.0% |
| Q3 2018 | $7,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |